HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - colon+cancer
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Human T Cell Receptors for Treating Cancer
Abstract: T cell receptors (TCRs) are proteins that recognize antigens in the context of infected or transformed cells and activate T cells to mediate an immune response and destroy abnormal cells. TCRs consist of two domains, one variable domain that recognizes the antigen and one constant region that helps the TCR anchor to the membrane and transmit...
Published: 4/22/2025
|
Updated: 8/2/2023
|
Inventor(s):
Richard Morgan
,
Nachimuthu Chinnasamy
,
Steven Rosenberg
Keywords(s):
COLON CANCER
,
Hepatocellular cancer
,
MELANOMA
,
PROSTATE CANCER
,
SSX
Category(s):
TherapeuticArea > Oncology
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
High Affinity Nanobodies Targeting B7-H3 (CD276) for Treating Solid Tumors
Summary: The NCI seeks licensing and/or co-development research collaborations for CD276-targeting camel nanobodies. Description of Technology: CD276 (also called B7-H3) is a pan-cancer antigen expressed in multiple solid tumors and an emerging cancer target. CD276 protein is overexpressed in pancreatic cancer, prostate cancer, breast cancer, colon...
Published: 4/24/2026
|
Updated: 8/2/2023
|
Inventor(s):
Mitchell Ho
,
Brad St. Croix
,
Ruixue Wang
,
Dan Li
Keywords(s):
ADC
,
Antibody-drug Conjugate
,
B7-H3
,
BREAST CANCER
,
CAR
,
CD276
,
chimeric antigen receptor
,
COLON CANCER
,
Glioma
,
HO
,
lung cancer
,
Nanobodies
,
Neuroblastoma
,
OVARIAN CANCER
,
Pancreatic Cancer
,
solid tumors
Category(s):
Application > Therapeutics
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
Home
|
Search
|
RSS
|
Subscribe
© 2026. All Rights Reserved. Powered by
Inteum